Relationship between the serum GDF-15 concentration and muscle function in female patients receiving aortic valve replacement (TAVR, SAVR): Comparison with healthy elderly female subjects.

ANOVA, analysis of variance AS, aortic stenosis AWGS, Asian Working Group for Sarcopenia Aortic valve replacement BNP, brain natriuretic peptide CFS, Clinical Frailty Scale CHF, chronic heart failure ELISA, enzyme-linked immunosorbent assay GDF, growth differentiation factor GH, growth hormone Growth differentiation factor −15 LVEF, left ventricular ejection fraction NYHA, New York Heart Association PAH, pulmonary arterial hypertension ROC, receiver-operating characteristics SAVR, conventional surgical aortic valve replacement SMI, skeletal muscle mass index Sarcopenia TAK1, TGFβ-activated kinase 1 TAVR, transcatheter aortic valve replacement TGF, transforming growth factor VO2, oxygen uptake eGFR, estimated glomerular filtration rate hsCRP, high-sensitive C-reactive protein

Journal

International journal of cardiology. Heart & vasculature
ISSN: 2352-9067
Titre abrégé: Int J Cardiol Heart Vasc
Pays: Ireland
ID NLM: 101649525

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 14 02 2022
revised: 21 03 2022
accepted: 11 04 2022
entrez: 2 5 2022
pubmed: 3 5 2022
medline: 3 5 2022
Statut: epublish

Résumé

Sarcopenia is closely associated with postoperative prognosis in patients undergoing cardiovascular surgery. Growth differentiation factor (GDF)-15 is involved in the pathogenesis of cardiovascular disease. We examined the relationship between the serum GDF-15 concentration and muscle function in patients receiving aortic valve replacement and healthy elderly subjects. Forty-three female patients undergoing aortic valve surgery (79.9 ± 6.4 years; transcatheter aortic valve replacement [TAVR] n = 19, conventional surgical aortic valve replacement [SAVR] n = 24) and 64 healthy elderly female subjects (75.9 ± 6.1 years) were included. Walking speed, grip strength, and skeletal muscle mass index (SMI) by a multifrequency bioelectrical impedance analyzer were measured to determine the presence of sarcopenia. Preoperative serum GDF-15 concentration was measured by enzyme-linked immunosorbent assay. The GDF-15 level was higher in patients receiving aortic valve replacement than in healthy elderly subjects (aortic valve replacement: 1624 ± 1186 pg/mL vs. healthy: 955 ± 368 pg/mL, p < 0.001). Multivariate linear regression analysis showed that the serum GDF-15 level determined grip strength independently of the high-sensitivity C-reactive protein level and eGFR, even after adjusting for age (β = -0.318, p = 0.025). Sarcopenia was found in 12.5% of healthy elderly subjects, 83.3% of patients with TAVR, and 64.3% of patients with SAVR. The GDF-15 concentration that defined sarcopenia was 1109 pg/mL in subjects including patients receiving aortic valve replacement. The preoperative serum GDF-15 concentration, which was higher in female patients receiving aortic valve replacement than in healthy elderly subjects, may be a serum marker of sarcopenia.

Identifiants

pubmed: 35495578
doi: 10.1016/j.ijcha.2022.101032
pii: S2352-9067(22)00081-1
pmc: PMC9043358
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101032

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Eur Heart J. 2013 Feb;34(7):512-9
pubmed: 23178647
J Clin Med. 2021 Feb 02;10(3):
pubmed: 33540756
Circ J. 2008 Mar;72(3):489-91
pubmed: 18296852
JACC Heart Fail. 2019 Dec;7(12):1001-1011
pubmed: 31779921
EMBO Mol Med. 2017 Aug;9(8):1150-1164
pubmed: 28572090
Int J Cardiol Heart Vasc. 2020 Oct 21;31:100651
pubmed: 33134478
JAMA Netw Open. 2020 Oct 1;3(10):e2020836
pubmed: 33074327
J Clin Med. 2019 Oct 01;8(10):
pubmed: 31581569
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
Cell Metab. 2016 Jun 14;23(6):1207-1215
pubmed: 27304512
Ageing Res Rev. 2015 Jul;22:58-71
pubmed: 25962896
Eur J Heart Fail. 2011 Jul;13(7):734-6
pubmed: 21467027
N Engl J Med. 2019 May 2;380(18):1706-1715
pubmed: 30883053
Circulation. 2017 May 23;135(21):2013-2024
pubmed: 28302751
Thorax. 2019 Feb;74(2):164-176
pubmed: 30554141
Circulation. 2011 May 17;123(19):2101-10
pubmed: 21536998
J Am Coll Cardiol. 2007 Sep 11;50(11):1054-60
pubmed: 17825714

Auteurs

Taira Fukuda (T)

Department of Liberal Arts and Human Development, Kanagawa University of Human Services, Yokosuka, Kanagawa 238-8522, Japan.

Toshiaki Nakajima (T)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Hiroko Yazawa (H)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Suguru Hirose (S)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Jun Yokomachi (J)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Takashi Kato (T)

Department of Cardiovascular Surgery, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Riichi Nishikawa (R)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Nobuo Koshiji (N)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Michiaki Tokura (M)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Takahisa Nasuno (T)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Setsu Nishino (S)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Syotaro Obi (S)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Ikuko Shibasaki (I)

Department of Cardiovascular Surgery, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Tomoaki Kanaya (T)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Fumitaka Nakamura (F)

Third Department of Internal Medicine, Teikyo University, Chiba Medical Center, Ichihara, Chiba 299-0111, Japan.

Hirotsugu Fukuda (H)

Department of Cardiovascular Surgery, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Shichiro Abe (S)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Masashi Sakuma (M)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Shigeru Toyoda (S)

Department of Cardiovascular Medicine, School of Medicine, Dokkyo Medical University, Shimotsuga-gun, Tochigi 321-0293, Japan.

Classifications MeSH